Literature DB >> 15292915

Cellular delivery of a double-stranded oligonucleotide NFkappaB decoy by hybridization to complementary PNA linked to a cell-penetrating peptide.

L Fisher1, U Soomets, V Cortés Toro, L Chilton, Y Jiang, U Langel, K Iverfeldt.   

Abstract

The activation of nuclear factor kappaB (NFkappaB) is a key event in immune and inflammatory responses. In this study, a cell-penetrating transport peptide, transportan (TP) or its shorter analogue TP 10, was used to facilitate the cellular uptake of an NFkappaB decoy. Peptide nucleic acid (PNA) hexamer or nonamer was linked to the transport peptide by a disulfide bond. NFkappaB decoy oligonucleotide consisted of a double-stranded consensus sequence corresponding to the kappaB site localized in the IL-6 gene promoter, 5'-GGGACTTTCCC-3', with a single-stranded protruding 3'-terminal sequence complementary to the PNA sequence was hybridized to the transport peptide-PNA construct. The ability of the transport peptide-PNA-NFkappaB decoy complex to block the effect of interleukin (IL)-1beta-induced NFkappaB activation and IL-6 gene expression was analyzed by electrophoretic mobility shift assay and reverse transcriptase-polymerase chain reaction in rat Rinm5F insulinoma cells. Preincubation with transport peptide-PNA-NFkappaB decoy (1 microM, 1 h) blocked IL-1beta-induced NFkappaB-binding activity and significantly reduced the IL-6 mRNA expression. The same concentration of NFkappaB decoy in the absence of transport peptide-PNA had no effect even after longer incubations. Our results showed that binding of the oligonucleotide NFkappaB decoy to the nonamer PNA sequence resulted in a stable complex that was efficiently translocated across the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292915     DOI: 10.1038/sj.gt.3302291

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  10 in total

1.  Effect of a Flexible Linker on Recombinant Expression of Cell-Penetrating Peptide Fusion Proteins and Their Translocation into Fungal Cells.

Authors:  Zifan Gong; Mackenzie T Walls; Alisha N Karley; Amy J Karlsson
Journal:  Mol Biotechnol       Date:  2016-12       Impact factor: 2.695

Review 2.  Cell-penetrating peptides: achievements and challenges in application for cancer treatment.

Authors:  Meong Cheol Shin; Jian Zhang; Kyoung Ah Min; Kyuri Lee; Youngro Byun; Allan E David; Huining He; Victor C Yang
Journal:  J Biomed Mater Res A       Date:  2013-07-30       Impact factor: 4.396

3.  Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers.

Authors:  Takehiko Shiraishi; Peter E Nielsen
Journal:  Artif DNA PNA XNA       Date:  2011 Jul-Dec

4.  Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.

Authors:  Li-Li Zou; Jie-Lan Ma; Tao Wang; Tang-Bin Yang; Chang-Bai Liu
Journal:  Curr Neuropharmacol       Date:  2013-03       Impact factor: 7.363

5.  Recent developments in peptide-based nucleic acid delivery.

Authors:  Sandra Veldhoen; Sandra D Laufer; Tobias Restle
Journal:  Int J Mol Sci       Date:  2008-07-16       Impact factor: 6.208

Review 6.  Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.

Authors:  Frederic Heitz; May Catherine Morris; Gilles Divita
Journal:  Br J Pharmacol       Date:  2009-03-20       Impact factor: 8.739

7.  Cell penetrating peptides in the delivery of biopharmaceuticals.

Authors:  Were Ll Munyendo; Huixia Lv; Habiba Benza-Ingoula; Lilechi D Baraza; Jianping Zhou
Journal:  Biomolecules       Date:  2012-03-30

Review 8.  Use of Cell-Penetrating Peptides in Dendritic Cell-Based Vaccination.

Authors:  Sangho Lim; Ja-Hyun Koo; Je-Min Choi
Journal:  Immune Netw       Date:  2016-02-25       Impact factor: 6.303

9.  Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs).

Authors:  Zhipeng Wang; Davit A Potoyan; Peter G Wolynes
Journal:  BMC Syst Biol       Date:  2018-01-30

Review 10.  Cell-Penetrating Peptides and Transportan.

Authors:  Ülo Langel
Journal:  Pharmaceutics       Date:  2021-06-29       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.